ValiRx plc (LON:VAL – Get Free Report)’s share price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 0.35 and traded as high as GBX 0.41. ValiRx shares last traded at GBX 0.36, with a volume of 11,512,358 shares changing hands.
ValiRx Price Performance
The stock has a market capitalization of £2.64 million, a price-to-earnings ratio of -0.38 and a beta of 0.59. The company has a current ratio of 6.65, a quick ratio of 1.27 and a debt-to-equity ratio of 0.44. The company’s 50 day moving average is GBX 0.35 and its 200 day moving average is GBX 0.51.
ValiRx (LON:VAL – Get Free Report) last released its quarterly earnings data on Monday, September 29th. The company reported GBX (0.22) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. Research analysts anticipate that ValiRx plc will post -1.74 EPS for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- The Last Gold Bull Market
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
